Intrathecal immunoreactivity in people with or without previous infectious mononucleosis

Daniel Jons1,2, Henrik Zetterberg3,4,5,6, Clas Malmeström1,2

  • 1Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Abstract

Insights

Infectious mononucleosis (IM) may trigger long-term inflammation, potentially leading to multiple sclerosis (MS) endophenotypes. Cerebrospinal fluid analysis post-IM showed elevated inflammatory markers, suggesting a link requiring further investigation.

Area of Science:

  • Neuroimmunology
  • Infectious Disease Immunology
  • Biomarker Discovery

Background:

  • Infectious mononucleosis (IM) is linked to an increased risk of multiple sclerosis (MS).
  • The precise biological mechanisms underlying this association remain unclear.
  • Investigating long-term inflammatory sequelae of IM is crucial for understanding MS pathogenesis.

Purpose of the Study:

  • To test the hypothesis that IM can cause long-term inflammatory activity resembling an MS endophenotype.
  • To analyze cerebrospinal fluid (CSF) cyto-/chemokine levels in individuals post-IM.
  • To explore potential presymptomatic MS traits following IM.

Main Methods:

  • Assayed seven MS-relevant CSF cyto-/chemokines (IL-1b, IL-6, YKL-40, TNF-alpha, IL-8, CCL2, IP-10).
  • Compared CSF levels in individuals 10 years post-IM (n=22) with controls without IM history (n=19).
  • Included an MS patient group (n=23) as a reference.

Main Results:

  • CSF levels of IP-10, YKL-40, and CCL-2 were significantly higher in the post-IM group compared to controls.
  • A trend towards elevated levels of all seven assayed cyto-/chemokines was observed in the post-IM group.
  • The observed trend, while directionally consistent, did not reach statistical significance in multivariate analysis.

Conclusions:

  • The findings do not refute the hypothesis linking IM sequelae to MS endophenotypes.
  • A stepwise inflammatory process from IM to an MS presymptomatic trait is plausible in a subset of patients.
  • Larger cohort studies are needed to confirm these preliminary findings with adequate statistical power.